Carolina Neurosurgery & Spine Associates’ Dr. Andrew Sumich is one of a handful of physiatrists across the country participating in trials of Relievant Medsystems' revolutionary technology that can reduce long-term pain for patients with chronic low back pain: the Intracept Spine Procedure.

The secret to the procedure lies in new research, which deepens the medical understanding of spinal anatomy. While most patients experiencing low back pain are treated for discogenic pain, recent findings have revealed that pain can actually originate from vertebral endplates, the bones found on either side of the disc.

Intracept targets the basivertebral nerve in a minimally invasive outpatient procedure, which improves function and decreases pain, even in the long term — a differentiating factor from many other low back pain treatment options.

Dr. Sumich has worked with approximately 40 patients in FDA-approved trials and has seen remarkable results firsthand, claiming that many procedures have resulted in “a home run” for pain relief.

He shares when the procedure is a viable option for those experiencing chronic lower back pain, when other treatment options may be a better fit, and discusses the profile of an ideal candidate for the revolutionary procedure.

Tune in to episode #41 of Back Talk Doc with Dr. Sumich to learn about the nitty-gritty of this medical procedure and how it’s transforming patients’ lives by reducing low back pain.

💡 Featured Expert 💡

Name: Andrew Sumich, MD

What he does: Dr. Andrew Sumich is a member of the Carolina Neurosurgery & Spine team. He is a board certified physiatrist, specializing in interventional spine care.

Company: Carolina Neurosurgery & Spine Associates

Words of wisdom: “Where we put medicine matters in terms of what's hurting or not.”

Connect: LinkedIn

⚓ Anchor Points ⚓

Top takeaways from this Back Talk Doc episode

★ There’s no one-size-fits-all for treating pain. There are many different causes for pain. Pain generation is an essential part of a medical diagnosis because it signals which treatment plans are most likely to benefit the patient. Not all pain indicates the same root cause, so while The Intracept Procedure may be a good fit for some candidates, it’s not a cure-all.

★ The Intracept Procedure targets vertebrogenic pain. Medical understanding of the spine continues to evolve. The role of endplates in the spine have just recently gained increased attention.

While most cases of chronic low back pain are treated as discogenic disorders, advanced and new understanding of the role of vertebral endplates has changed how to decrease pain for some patients. Vertebrogenic pain, unlike disc-oriented pain, is transmitted through the basivertebral nerve. The Intracept Procedure targets the nerve with a one-time ablation.

★ The results are “staggering.” Intracept’s parent company, Relievant Medsystems, has tracked results of the surgical procedure over a five-year period — a shockingly long time period for medical technology studies. The long-term efficacy of the procedure is unlike anything else that Dr. Sumich has seen in spine care. He’s also seen anecdotal evidence in the improved quality of life from the trial participants he’s treated.

⚕️ Episode Insights ⚕️

[00:00] Check out our sponsor: